FSD Pharma Inc. HUGE
Set alert
0.09 0.00 0.00%
At close · Aug 14
0.087 Day range 0.1042
52-week range unavailable
- Open
- 0.095
- Prev close
- 0.0899
- Mkt cap
- 66.67K
- Vol
- 22.02M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.087
- High
- 0.1042
- Forward P/E
- -0.75
- Beta
- 0.00
- Short ratio
- 0.11
- Inst. own
- 2.69%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 8.13
- 200-d avg
- 36.69
- 1y target
- 2.60
Financial health
Altman Z-Score
-16.81 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -127×
FY 2015 5y median -80.6× FY 2023
P/S 0.0×
FY 2015 5y median 0.0× FY 2023
P/B 179×
FY 2015 5y median 65.0× FY 2023
P/FCF -215×
FY 2015 5y median -109× FY 2023
EV/EBITDA -147×
FY 2015 5y median -86.6× FY 2023
EV/Sales 0.0×
FY 2015 5y median 0.0× FY 2023
FCF Yield -0.5%
FY 2015 5y median -0.9% FY 2023
Profitability
Gross Margin 0.0%
FY 2015 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2015 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2015 5y median 0.0% FY 2023
ROE -140.3%
FY 2015 5y median -82.4% FY 2023
ROIC -150.2%
FY 2015 5y median -79.4% FY 2023
ROA -106.2%
FY 2015 5y median -78.0% FY 2023
Growth (YoY)
Revenue 0.0%
FY 2015 FY 2023
Operating Income 27.3%
FY 2015 FY 2023
EPS (diluted) 21.7%
FY 2015 FY 2023
Free Cash Flow 61.6%
FY 2015 FY 2023
Financial Health
Current Ratio 2.4×
FY 2015 5y median 2.4× FY 2023
Quick Ratio 2.4×
FY 2015 5y median 2.4× FY 2023
Debt / Equity 0.0×
FY 2015 5y median 0.0× FY 2023
Net Debt / EBITDA 0.1×
FY 2015 5y median 0.7× FY 2023
Interest Coverage -65452×
FY 2015 5y median -486× FY 2023
Dividends
Dividend Yield 0.0%
FY 2015 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2015 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31